Cargando…
Systemic glucocorticoid use and the occurrence of flares in psoriatic arthritis and psoriasis: a systematic review
OBJECTIVES: The use of systemic glucocorticoids (SGCs) is traditionally discouraged in the treatment of PsA and psoriasis due to the risk of psoriatic flares. However, despite this recommendation, SGCs are frequently prescribed for these patients. In this study we reappraise the old paradigm that SG...
Autores principales: | Vincken, Nanette L A, Balak, Deepak M W, Knulst, André C, Welsing, Paco M J, van Laar, Jacob M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629346/ https://www.ncbi.nlm.nih.gov/pubmed/35285486 http://dx.doi.org/10.1093/rheumatology/keac129 |
Ejemplares similares
-
Do Patients with Psoriatic Arthritis Have More Severe Skin Disease than Patients with Psoriasis Only? A Systematic Review and Meta-Analysis
por: Pouw, Juliëtte N., et al.
Publicado: (2022) -
Comparative short-term risks of infection and serious infection in patients receiving biologic and small-molecule therapies for psoriasis and psoriatic arthritis: a systemic review and network meta-analysis of randomized controlled trials
por: Chiu, Hsien-Yi, et al.
Publicado: (2023) -
Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysis
por: Mease, Philip J, et al.
Publicado: (2021) -
Comparative effectiveness of guselkumab in psoriatic arthritis: updates to a systematic literature review and network meta-analysis
por: Mease, Philip J, et al.
Publicado: (2022) -
Tissue‐Resident Memory CD8+ T Cells From Skin Differentiate Psoriatic Arthritis From Psoriasis
por: Leijten, Emmerik F., et al.
Publicado: (2021)